ATE503489T1 - Behandlung von akutem nierenversagen mit löslichem thrombomodulin - Google Patents

Behandlung von akutem nierenversagen mit löslichem thrombomodulin

Info

Publication number
ATE503489T1
ATE503489T1 AT06825898T AT06825898T ATE503489T1 AT E503489 T1 ATE503489 T1 AT E503489T1 AT 06825898 T AT06825898 T AT 06825898T AT 06825898 T AT06825898 T AT 06825898T AT E503489 T1 ATE503489 T1 AT E503489T1
Authority
AT
Austria
Prior art keywords
soluble thrombomodulin
renal failure
acute renal
treatment
thrombomodulin
Prior art date
Application number
AT06825898T
Other languages
English (en)
Inventor
Brian Grinnell
Thurman Mckinney
Bruce Molitoris
Original Assignee
Lilly Co Eli
Univ Indiana Res & Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Univ Indiana Res & Tech Corp filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE503489T1 publication Critical patent/ATE503489T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06825898T 2005-10-13 2006-10-12 Behandlung von akutem nierenversagen mit löslichem thrombomodulin ATE503489T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72637605P 2005-10-13 2005-10-13
PCT/US2006/040069 WO2007047430A2 (en) 2005-10-13 2006-10-12 Method of treating acute failure with thrombomodulin variant

Publications (1)

Publication Number Publication Date
ATE503489T1 true ATE503489T1 (de) 2011-04-15

Family

ID=37670944

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06825898T ATE503489T1 (de) 2005-10-13 2006-10-12 Behandlung von akutem nierenversagen mit löslichem thrombomodulin

Country Status (13)

Country Link
US (1) US20080255047A1 (de)
EP (1) EP1948216B1 (de)
JP (1) JP5405829B2 (de)
AT (1) ATE503489T1 (de)
CA (1) CA2625888C (de)
CY (1) CY1112438T1 (de)
DE (1) DE602006021048D1 (de)
DK (1) DK1948216T3 (de)
ES (1) ES2360610T3 (de)
PL (1) PL1948216T3 (de)
PT (1) PT1948216E (de)
SI (1) SI1948216T1 (de)
WO (1) WO2007047430A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2754447A3 (de) * 2006-12-12 2014-11-12 Indiana University Research and Technology Corporation Behandlung von akutem nierenversagen mit löslichen thrombomodulin varianten
EA201170679A1 (ru) * 2008-11-12 2012-04-30 Эли Лилли Энд Компани Композиции и способы применения вариантов тромбомодулина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2022713A1 (en) * 1989-08-11 1991-02-12 Nils U. Bang Human thrombomodulin derivatives
JP3517236B2 (ja) * 1992-02-05 2004-04-12 シェーリング アクチェンゲゼルシャフト プロテアーゼ−耐性トロンボモジュリン・アナログ
EP0689843B1 (de) * 1993-12-17 2003-09-10 Mochida Pharmaceutical Co., Ltd. Lösliches thrombomodulin enthaltende zubereitung
US20050106124A1 (en) * 2003-02-25 2005-05-19 Sehgal Lakshman R. Therapeutic applications of thrombomodulin gene via viral and non-viral vectors

Also Published As

Publication number Publication date
US20080255047A1 (en) 2008-10-16
DE602006021048D1 (de) 2011-05-12
CA2625888A1 (en) 2007-04-26
DK1948216T3 (da) 2011-06-06
SI1948216T1 (sl) 2011-07-29
CA2625888C (en) 2015-09-22
JP5405829B2 (ja) 2014-02-05
CY1112438T1 (el) 2015-12-09
PT1948216E (pt) 2011-05-06
ES2360610T3 (es) 2011-06-07
PL1948216T3 (pl) 2011-10-31
EP1948216B1 (de) 2011-03-30
WO2007047430A2 (en) 2007-04-26
EP1948216A2 (de) 2008-07-30
WO2007047430A3 (en) 2007-05-24
JP2009511597A (ja) 2009-03-19
WO2007047430A8 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
ATE551996T1 (de) Behandlung oder prävention von diabetes mit cannabidiol
CY1120022T1 (el) Θεραπεια παιδιατρικης οξειας λεμφοβλαστικης λευχαιμιας
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
MX391921B (es) Nepicastat para usarse en el tratamiento de dependencia
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
CY1116938T1 (el) Αναπληρωτικη θεραπεια της ασθενειας huntington και αλλων ασθενειων πολυγλουταμiνης
DK1809661T3 (da) Humant interferon-beta-mutein
EA200870091A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для снятия боли
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
EA200870088A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов и глюкозы в крови
EA200701995A1 (ru) Способы уменьшения кальцификации
EP2754447A3 (de) Behandlung von akutem nierenversagen mit löslichen thrombomodulin varianten
CY1112438T1 (el) Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινη
ATE380554T1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
ITMI20040954A1 (it) Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
RU2007122391A (ru) S-миртазапин для лечения приливов
EA200702201A1 (ru) Рофлумиласт для лечения лёгочной гипертензии
DE602008003411D1 (de) Verwendung von d-ribose zur behandlung von vorhofflimmern
TN2011000206A1 (en) Compositions and methods of use soluble thrombomodulin variants
DE602006020838D1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
ATE546137T1 (de) Pharmazeutische zusammensetzungen zur behandlung von warzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1948216

Country of ref document: EP